Stocks · Health care · Surgical & Medical Instruments & Apparatus

Becton Dickinson

BDX Clue Score44
United States Fiscal year ends September CIK 0000010795 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Michael Feld
26 Oct 2026
EVP, Chief Revenue Officer
Sold on a plan
76
$198.13
$15.06K
Michael Feld
28 Sep 2026
EVP, Chief Revenue Officer
Sold on a plan
76
$183.70
$13.96K
Michael Feld
26 Aug 2026
EVP, Chief Revenue Officer
Sold on a plan
165
$188.49
$31.10K
Thomas E Polen Jr
13 Aug 2026
Chairman, CEO and President
Sold after exercise
4,152
$185.00
$768.12K
Roland Goette
11 Aug 2026
EVP and President, EMEA
Sell
2,438
$180.84
$440.89K
Michael Feld
27 Jul 2026
EVP, Chief Revenue Officer
Sold on a plan
75
$157.13
$11.78K
Michael Feld
26 Jun 2026
EVP, Chief Revenue Officer
Sold on a plan
75
$152.80
$11.46K
Michael David Garrison
24 Jun 2026
EVP & Pres Med.Essntl&BioPharm
Sold on a plan
1,100
$145.66
$160.23K
Michael David Garrison
10 Jun 2026
EVP & Pres Med.Essntl&BioPharm
Sold on a plan
1,100
$151.48
$166.63K
Thomas E Polen Jr
1 Jun 2026
Chairman, CEO and President
Sold after exercise
2,764
$146.35
$404.51K
Michael Feld
26 May 2026
EVP, Chief Revenue Officer
Sold on a plan
75
$147.35
$11.05K
Michael Feld
27 Apr 2026
EVP, Chief Revenue Officer
Sold on a plan
74
$151.94
$11.24K
Michael Feld
26 Mar 2026
EVP, Chief Revenue Officer
Sold on a plan
75
$156.83
$11.76K
Michael Feld
26 Feb 2026
EVP, Chief Revenue Officer
Sold on a plan
75
$181.84
$13.64K
Bertram L Scott
18 Feb 2026
Director
Sell
953
$182.61
$174.03K
Michael Feld
26 Jan 2026
EVP, CRO & Pres. Life Sciences
Sold on a plan
75
$202.73
$15.20K
Michael David Garrison
15 Jan 2026
EVP & Pres Med.Essntl&BioPharm
Sold after exercise
1,010
$206.54
$208.61K
Michael David Garrison
15 Jan 2026
EVP & Pres Med.Essntl&BioPharm
Sold after exercise
600
$209.00
$125.40K
Michael Feld
26 Dec 2025
EVP, CRO & Pres. Life Sciences
Sold on a plan
74
$196.08
$14.51K
Michael David Garrison
17 Dec 2025
EVP & Pres Med.Essntl&BioPharm
Sold on a plan
629
$196.03
$123.30K
Michael Feld
1 Dec 2025
EVP, CRO & Pres. Life Sciences
Sold on a plan
75
$193.36
$14.50K
Bertram L Scott
7 Nov 2025
Director
Sell
217
$176.58
$38.32K

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 4
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 298,834
History held since 2 Nov 2006